Beijing Strong Biotechnologies, Inc.

Beijing Strong Biotechnologies, Inc. (BSBE) is a prominent Chinese company specializing in the research, development, manufacturing, and sales of in-vitro diagnostics (IVD) products and services. Established in 2001 and listed on the ChiNext board of the Shenzhen Stock Exchange in 2014, BSBE is recognized for its commitment to adhering to international standards in IVD technology. The company has developed a comprehensive range of diagnostic systems, including those for biochemical testing, coagulation testing, blood typing, point-of-care testing (POCT), pathology diagnostics, and liquid biopsy CTC detection. BSBE operates a robust biochemistry testing platform and offers a wide array of diagnostic reagents and fully automated analyzers. The company has built a global marketing and service network, positioning itself as a leader in the biochemistry field. BSBE has established strategic partnerships with notable domestic and international enterprises, such as Abbott and Roche, enhancing its technological capabilities and expanding its presence in the international IVD market. With a strong focus on R&D and a commitment to quality, BSBE continues to introduce new testing projects and aims for sustained growth in the industry.

(1) Large scale, advanced technology, excellent quality As a domestic player in the in vitro diagnostics industry, BSBE is committed to establishing an outstanding biochemistry testing platform. Currently, BSBE possess a comprehensive range of biochemistry diagnostic reagents and fully automated biochemistry analyzers. BSBE’s biochemistry development technology platform related techniques are at the forefront both domestically and internationally, ensuring the provision of consistently stable and reliable products. Through years of steady development and accumulation, BSBE has built a global marketing and service network, positioning itselves as a leader in the field of biochemistry. (2) Comprehensive range of analytes BSBE has been focusing on the research and development of in vitro diagnostic products, with a dedicated team of professionals. The product registration certificates by SFDA cover a wide range of products, and the company is particularly known for continuously introducing new testing projects. (3) "Running with the giants"- Expanding into the international market and demonstrating technical prowess Since 2013, BSBE has progressively established strategic partnerships with well-known domestic and international enterprises such us Abbott, Roche, Hitachi, and Mindray. The “LICENSE, TECHNOLOGY TRANSFER AND SUPPLY AGREEMENT” signed with Abbott in 2016 marked a pioneering step for China’s IVD technology exports, and also laid the foundation for long-term cooperation with foreign enterprises. After more than a decade of substantial development, BSBE has grown to become one of China's leading IVD product manufacturers, gradually gaining a foothold in the international IVD market. (4) Bright prospects for future growth Leveraging the position as a listed company, BSBE will intensify efforts to expand externally and maintain its growth trajectory.